Loading company…
McLean-based precision oncology company offering AI-driven therapy recommendations through its Perthera Report.
Perthera, Inc. provides an AI precision oncology platform whose core product, the Perthera Report, combines multi-omic test results with patient data to rank therapy options for oncologists. Founded in 2012 in McLean, US, the company has raised a total of USD 0.75 mn across six deals, and its latest round was a VENTURE DEBT round of USD 2.10 mn on January 2, 2019. Donna Tuths and Gary Gregory are the current CEOs, and the company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in